Kwashiorkor and the Gut Microbiota
Wendy S. Garrett, M.D., Ph.D.
Malnutrition is a global health problem and a major contributor to childhood morbidity and mortality. Kwashiorkor and marasmus are two forms of severe undernutrition prevalent in re gions confronting food insecurity and high bur dens of infectious disease. The cause of kwashi orkor, a form of malnutrition notable for stunted growth, generalized edema, dermatologic mani festations, and hepatic steatosis, has remained elusive. Over the past 60 years, there have been many ideas about the pathogenesis of kwashior kor, including inadequate dietary protein, the leaky gut syndrome (compromised gut epithelial barrier), and intestinal inflammation. Results of a study by Smith et al. 1 now implicate the gut microbiota, the vast collection of microbes that reside within the intestinal tract, as a central factor in the cause of kwashiorkor. A clinical trial recently reported in the Journal showed that giving oral antibiotic agents to children with se vere acute malnutrition was associated with de creased mortality and an increased rate of recov ery, 2 further strengthening the case for a direct association between the microbiota and malnu trition.
Using both human fecal surveys and mouse models, Smith et al. have begun to elucidate the contribution of the gut microbiota and diet to kwashiorkor (see Fig. 1 for a schematic repre sentation of their experimental design). Their study also identifies potential mechanisms un derpinning the recognized shortcomings in cur rent treatment strategies for undernutrition that use readytouse therapeutic food (RUTF; usual ly a fortified spread consisting of peanut paste, milk powder, oil, sugar, and a micronutrient supplement). The findings of Smith et al. unveil new targets in the microbiota for the treatment of kwashiorkor and suggest that preclinical screening approaches based on mouse models may be useful for guiding interventions.
The human gut microbiota make up a com plex and diverse microbial community that is notable for its variation from person to person. In a recent study from the laboratory of Jeffrey Gordon, the senior author of the study by Smith et al., deep sequencing of the gut microbiota from people from the United States, Venezuela, and Malawi identified changes in the microbi ome during postnatal development. 3 Previous studies of the gut microbiome have suggested that using monozygotic twins or individual per sons as their own controls can help control for the effects of human genetic variation and envi ronmental exposure on the microbiota. 4,5 With these factors in mind, Smith et al. recruited twin pairs in rural southern Malawi for a study designed to resolve the kwashiorkor conundrum and establish the microbiota as a key player in the pathogenesis of kwashiorkor.
The study included monozygotic and dizy gotic twins as well as twins discordant for kwashiorkor. When a twin with kwashiorkor began receiving RUTF, the healthy twin received it, too. A total of 15% of the twin pairs were monozygotic twins, which allowed the investi gators to determine whether zygosity contribut ed to a propensity for malnutrition or to the dis cordance for kwashiorkor, but no significant differences were found. The twin pairs were fol lowed prospectively, allowing for comparisons of the microbiota before and after the diagnosis of kwashiorkor, as well as while the children were and were not receiving RUTF. In the healthy twins, whether their twin siblings were healthy or had kwashiorkor, there were signifi cant differences over time in the microbiota, and these patterns were consistent with devel opmental maturation of the gut microbiota. However, these changes were not observed in the twins with kwashiorkor, suggesting that the maturation of their microbiota was stunted.
To determine whether the composition of microbiota represents a causal factor in kwashi orkor, the investigators used fecal transplanta tion in gnotobiotic mice. Before undergoing 1747 clinical implications of basic research transplantation, these mice had no microbes, and during the experiments they received sterile food and water while living in specialized isola tors with filtered air. One group of mice re ceived fecal transplants from healthy persons, and the other group received transplants from persons with kwashiorkor; both groups of mice were then fed a diet that mimicked the foods consumed in rural Malawi -a critical experi mental factor. The mice that received fecal transplants from human donors with kwashior kor lost a significant amount of weight on the Malawian diet.
Several differences were noted between the two groups of mice. There were differences both in the microbiota and metabolic profiles in the mice that received transplants with microbi ota from persons with kwashiorkor, as com pared with those receiving transplants with mi crobiota from healthy persons, both when those persons were receiving RUTF and when they were not. Many of the RUTFassociated changes were transient, especially in mice receiving mi crobiota from the fecaltransplant donors with kwashiorkor. Metabolic analyses suggested that the microbiota of persons in whom kwashiorkor develops generate products, such as inhibitors of enzymes in the tricarboxylic acid cycle, that can compromise effective energy metabolism.
Smith et al. have identified potential targets for kwashiorkor that are rooted in the microbio ta. They also found specific microbes, metabolic pathways, and metabolites that correlated with a positive response to RUTF, as well as signals that correlated with a lack of sustained improve ment. Their work, and that of other microbiome researchers, not only provides a basis for under standing developmental patterns in healthy gut microbiota but also establishes robust preclini cal models to improve food and microbialbased therapies for malnutrition.
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